198 related articles for article (PubMed ID: 25139674)
1. Progression of muscle histopathology but not of spliceopathy in myotonic dystrophy type 2.
Cardani R; Giagnacovo M; Rossi G; Renna LV; Bugiardini E; Pizzamiglio C; Botta A; Meola G
Neuromuscul Disord; 2014 Dec; 24(12):1042-53. PubMed ID: 25139674
[TBL] [Abstract][Full Text] [Related]
2. Ribonuclear inclusions and MBNL1 nuclear sequestration do not affect myoblast differentiation but alter gene splicing in myotonic dystrophy type 2.
Cardani R; Baldassa S; Botta A; Rinaldi F; Novelli G; Mancinelli E; Meola G
Neuromuscul Disord; 2009 May; 19(5):335-43. PubMed ID: 19345584
[TBL] [Abstract][Full Text] [Related]
3. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
[TBL] [Abstract][Full Text] [Related]
4. Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2.
Cardani R; Giagnacovo M; Botta A; Rinaldi F; Morgante A; Udd B; Raheem O; Penttilä S; Suominen T; Renna LV; Sansone V; Bugiardini E; Novelli G; Meola G
J Neurol; 2012 Oct; 259(10):2090-9. PubMed ID: 22407275
[TBL] [Abstract][Full Text] [Related]
5. Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2.
Cardani R; Mancinelli E; Rotondo G; Sansone V; Meola G
Eur J Histochem; 2006; 50(3):177-82. PubMed ID: 16920640
[TBL] [Abstract][Full Text] [Related]
6. Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy.
Cardani R; Mancinelli E; Sansone V; Rotondo G; Meola G
Eur J Histochem; 2004; 48(4):437-42. PubMed ID: 15718211
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of CUGBP1 in skeletal muscle from adult classic myotonic dystrophy type 1 but not from myotonic dystrophy type 2.
Cardani R; Bugiardini E; Renna LV; Rossi G; Colombo G; Valaperta R; Novelli G; Botta A; Meola G
PLoS One; 2013; 8(12):e83777. PubMed ID: 24376746
[TBL] [Abstract][Full Text] [Related]
8. Gene expression analysis in myotonic dystrophy: indications for a common molecular pathogenic pathway in DM1 and DM2.
Botta A; Vallo L; Rinaldi F; Bonifazi E; Amati F; Biancolella M; Gambardella S; Mancinelli E; Angelini C; Meola G; Novelli G
Gene Expr; 2007; 13(6):339-51. PubMed ID: 17708420
[TBL] [Abstract][Full Text] [Related]
9. Ribonuclear inclusions as biomarker of myotonic dystrophy type 2, even in improperly frozen or defrozen skeletal muscle biopsies.
Cardani R; Mancinelli E; Giagnacovo M; Sansone V; Meola G
Eur J Histochem; 2009; 53(2):107-11. PubMed ID: 19683984
[TBL] [Abstract][Full Text] [Related]
10. Muscleblind-like 2 (Mbnl2) -deficient mice as a model for myotonic dystrophy.
Hao M; Akrami K; Wei K; De Diego C; Che N; Ku JH; Tidball J; Graves MC; Shieh PB; Chen F
Dev Dyn; 2008 Feb; 237(2):403-10. PubMed ID: 18213585
[TBL] [Abstract][Full Text] [Related]
11. A putative role of ribonuclear inclusions and MBNL1 in the impairment of gallbladder smooth muscle contractility with cholelithiasis in myotonic dystrophy type 1.
Cardani R; Mancinelli E; Saino G; Bonavina L; Meola G
Neuromuscul Disord; 2008 Aug; 18(8):641-5. PubMed ID: 18653337
[TBL] [Abstract][Full Text] [Related]
12. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
[TBL] [Abstract][Full Text] [Related]
13. A muscleblind knockout model for myotonic dystrophy.
Kanadia RN; Johnstone KA; Mankodi A; Lungu C; Thornton CA; Esson D; Timmers AM; Hauswirth WW; Swanson MS
Science; 2003 Dec; 302(5652):1978-80. PubMed ID: 14671308
[TBL] [Abstract][Full Text] [Related]
14. Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2.
Mankodi A; Teng-Umnuay P; Krym M; Henderson D; Swanson M; Thornton CA
Ann Neurol; 2003 Dec; 54(6):760-8. PubMed ID: 14681885
[TBL] [Abstract][Full Text] [Related]
15. Muscleblind-Like 1 and Muscleblind-Like 3 Depletion Synergistically Enhances Myotonia by Altering Clc-1 RNA Translation.
Choi J; Personius KE; DiFranco M; Dansithong W; Yu C; Srivastava S; Dixon DM; Bhatt DB; Comai L; Vergara JL; Reddy S
EBioMedicine; 2015 Sep; 2(9):1034-47. PubMed ID: 26501102
[TBL] [Abstract][Full Text] [Related]
16. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing.
Charlet-B N; Savkur RS; Singh G; Philips AV; Grice EA; Cooper TA
Mol Cell; 2002 Jul; 10(1):45-53. PubMed ID: 12150906
[TBL] [Abstract][Full Text] [Related]
17. Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice.
Manta A; Stouth DW; Xhuti D; Chi L; Rebalka IA; Kalmar JM; Hawke TJ; Ljubicic V
J Physiol; 2019 Mar; 597(5):1361-1381. PubMed ID: 30628727
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a New Molecular Diagnostic Assay for Detection of Myotonic Dystrophy Type 2.
Valaperta R; Lombardi F; Cardani R; Fossati B; Brigonzi E; Merli I; Sansone V; Merletti G; Spina E; Meola G; Costa E
Genet Test Mol Biomarkers; 2015 Dec; 19(12):703-9. PubMed ID: 26505324
[TBL] [Abstract][Full Text] [Related]
19. Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.
Arandel L; Polay Espinoza M; Matloka M; Bazinet A; De Dea Diniz D; Naouar N; Rau F; Jollet A; Edom-Vovard F; Mamchaoui K; Tarnopolsky M; Puymirat J; Battail C; Boland A; Deleuze JF; Mouly V; Klein AF; Furling D
Dis Model Mech; 2017 Apr; 10(4):487-497. PubMed ID: 28188264
[TBL] [Abstract][Full Text] [Related]
20. Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes.
Kim EY; Barefield DY; Vo AH; Gacita AM; Schuster EJ; Wyatt EJ; Davis JL; Dong B; Sun C; Page P; Dellefave-Castillo L; Demonbreun A; Zhang HF; McNally EM
JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30730308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
